Related Experiment Video

Updated: Jun 23, 2026

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

Assessing infection risk with biologic agents in RA: methodological challenges

Mark C Fisher1, Jeffrey D Greenberg

  • 1New York University Hospital for Joint Diseases, New York, NY 10003, USA.

Nature Reviews. Rheumatology
|May 5, 2009
PubMed

Insights

Patients with rheumatoid arthritis (RA) face higher infection risks, especially with new biologic disease-modifying antirheumatic drugs (DMARDs). Understanding study limitations is key to assessing infection risks associated with these RA treatments.

Area of Science:

  • Rheumatology
  • Immunology
  • Infectious Diseases

Background:

  • Patients with rheumatoid arthritis (RA) exhibit an elevated risk of infection compared to the general population.
  • The increasing use of biologic disease-modifying antirheumatic drugs (DMARDs) for RA treatment may reveal previously unidentified adverse events, including opportunistic and serious infections.

Purpose of the Study:

  • To analyze the infection risks associated with biologic DMARDs in RA patients.
  • To highlight the importance of understanding data limitations from clinical trials, registries, and meta-analyses for accurate interpretation of RA treatment outcomes.

Main Methods:

  • Review of data from randomized clinical trials, patient registries, and meta-analyses.
  • Comparative analysis of infection risks across different biologic agents used in RA treatment.

Main Results:

  • The majority of approved biologic agents for RA are associated with an increased risk of infection.
  • Potential differences exist between biologic agents regarding their impact on patient susceptibility to specific infections and overall immunocompetence.

Conclusions:

  • Biologic DMARDs, while effective for RA, necessitate careful monitoring for infection risks.
  • Further research is needed to differentiate the infection profiles of various biologic agents to optimize patient safety in RA management.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...